Farrukh Abbas, MD, FCCP, and Megan Conroy, MD, MAEd, FCCP, discuss the role of the care team in COPD diagnosis, recent changes in classifications and updates to the Global Initiative for Chronic Obstructive Lung Disease guidelines, how triple-inhaler therapies and biologics can be used to treat patients with COPD, and more.

Since the time of this recording, the US Food and Drug Administration has approved dupilumab as an add-on maintenance treatment for adult patients with inadequately controlled COPD with type 2 inflammation.

This podcast is a part of CHEST's Bridging Specialties®: Timely Diagnosis and Treatment for COPD program. Access more resources at chestnet.org/timely-diagnosis-COPD.